Vitamin C for the common cold and pneumonia

Hemilä et al., Polish Archives of Internal Medicine, doi:10.20452/pamw.16926, Jan 2025

Source

PDF

All
Studies

Meta
Analysis

https://c19early.org/hemila8.html

Vitamin C for COVID-19

6th treatment shown to reduce risk in September 2020, now with p = 0.00000002 from 75 studies, recognized in 22 countries.

Lower risk for mortality, ICU, hospitalization, and recovery.

No treatment is 100% effective. Protocols combine treatments.

6,200+ studies for 180+ treatments. c19early.org

Review of vitamin C for the common cold and pneumonia. Authors conclude that while regular vitamin C supplementation does not prevent common colds infections in the general population, it significantly reduces the severity and duration of colds by 15% when taken regularly at doses of 1 g/day or more. For individuals undertaking heavy physical activity, vitamin C halved the incidence of colds. Authors note that therapeutic trials have inconsistent results, but high doses of 6-8 g/day can decrease cold duration when initiated soon after symptom onset. For pneumonia, vitamin C was preventive in three historical trials under specific conditions but is unlikely to reduce risk in the general population. However, there is some evidence suggesting a treatment benefit for pneumonia, encouraging further research. Authors discuss the interaction of vitamin C with vitamin E, the safety profile of high-dose vitamin C, and bias against vitamin C in mainstream medicine. Authors include critical analysis of the methodologies, biases, and outcomes of the discussed trials. They suggest individual testing of high-dose vitamin C for colds given its safety and low cost.

Reviews covering vitamin C for COVID-19 include1-17.

Important missing comments or errors? Let us know.

1. Al-Khrasani et al., Do vitamins halt the COVID-19-evoked pro-inflammatory cytokines involved in the development of neuropathic pain?, Biomedicine & Pharmacotherapy, doi:10.1016/j.biopha.2025.118346.sciencedirect.com, doi.org.

2. Sanduzzi Zamparelli et al., Immune-Boosting and Antiviral Effects of Antioxidants in COVID-19 Pneumonia: A Therapeutic Perspective, Life, doi:10.3390/life15010113.mdpi.com, doi.org.

3. Fazli et al., Possible Link between Gut Microbiota, Diet, and COVID-19 Infection, Journal of Medical Bacteriology, 12:4, jmb.tums.ac.ir/index.php/jmb/article/view/525ac.ir.

4. Xie et al., The role of reactive oxygen species in severe acute respiratory syndrome coronavirus 2 (SARS-COV-2) infection-induced cell death, Cellular & Molecular Biology Letters, doi:10.1186/s11658-024-00659-6.biomedcentral.com, doi.org.

5. Kaushal, A., Nutraceuticals and pharmacological to balance the transitional microbiome to extend immunity during COVID-19 and other viral infections, Journal of Translational Medicine, doi:10.1186/s12967-024-05587-9.biomedcentral.com, doi.org.

6. Mu et al., Anti-inflammatory and Nutritional Interventions Against SARS-CoV-2: A Comprehensive Review, Journal of Agriculture and Food Research, doi:10.1016/j.jafr.2024.101422.sciencedirect.com, doi.org.

7. Hemilä et al., Rebound effect explains the divergence in survival after 5 days in a controlled trial on vitamin C for COVID-19 patients, Frontiers in Medicine, doi:10.3389/fmed.2024.1391346.frontiersin.org, doi.org.

8. Schloss et al., Nutritional deficiencies that may predispose to long COVID, Inflammopharmacology, doi:10.1007/s10787-023-01183-3.springer.com, doi.org.

9. Yamasaki et al., Pleiotropic Functions of Nitric Oxide Produced by Ascorbate for the Prevention and Mitigation of COVID-19: A Revaluation of Pauling’s Vitamin C Therapy, Microorganisms, doi:10.3390/microorganisms11020397.mdpi.com, doi.org.

10. Arora et al., Global Dietary and Herbal Supplement Use during COVID-19—A Scoping Review, Nutrients, doi:10.3390/nu15030771.mdpi.com, doi.org.

11. Foshati et al., Antioxidants and clinical outcomes of patients with coronavirus disease 2019: A systematic review of observational and interventional studies, Food Science & Nutrition, doi:10.1002/fsn3.3034.wiley.com, doi.org.

12. Hemilä (B) et al., Bias against Vitamin C in Mainstream Medicine: Examples from Trials of Vitamin C for Infections, Life, doi:10.3390/life12010062.mdpi.com, doi.org.

13. May et al., Therapeutic potential of megadose vitamin C to reverse organ dysfunction in sepsis and COVID-19, British Journal of Pharmacology, doi:10.1111/bph.15579.wiley.com, doi.org.

14. Hemilä (C) et al., Vitamin C and COVID-19, Frontiers in Medicine, doi:10.3389/fmed.2020.559811.frontiersin.org, doi.org.

15. Holford et al., Vitamin C—An Adjunctive Therapy for Respiratory Infection, Sepsis and COVID-19, Nutrients, doi:10.3390/nu12123760.mdpi.com, doi.org.

16. Feyaerts et al., Vitamin C as prophylaxis and adjunctive medical treatment for COVID-19?, Nutrition, doi:10.1016/j.nut.2020.110948.sciencedirect.com, doi.org.

17. Biancatelli et al., Quercetin and Vitamin C: An Experimental, Synergistic Therapy for the Prevention and Treatment of SARS-CoV-2 Related Disease (COVID-19), Frontiers in Immunology, doi:10.3389/fimmu.2020.01451.frontiersin.org, doi.org.

Hemilä et al., 13 Jan 2025, United Kingdom, peer-reviewed, 2 authors. Contact: harri.hemila@helsinki.fi.

This Paper Vitamin C All

Vitamin C for the common cold and pneumonia

MD Harri Hemilä, Elizabeth Chalker

Polish Archives of Internal Medicine, doi:10.20452/pamw.16926

This article provides an overview of vitamin C for preventing and treating respiratory infections. Studies in a wide variety of animals have shown vitamin C to be protective against infections. In controlled trials in the general human population, >1 g/day vitamin C did not prevent common colds. However, in 5 trials with participants undertaking heavy physical activity, vitamin C halved the incidence of colds. In 15 trials (N = 6244), regular supplementation of ≥1 g/day of vitamin C decreased the severity of colds by 15%. Results of therapeutic trials, in which vitamin C was initiated after common cold symptoms began, have been inconsistent. However, two therapeutic trials found that 6-8 g/day of vitamin C was twice as effective at reducing the duration of colds than 3-4 g/day. In three controlled trials, vitamin C prevented pneumonia, but the contexts were atypical: participants were schoolboys in a boarding school in the UK before WW-II, soldiers hospitalized for influenza A, and US marine recruits. It is unlikely that vitamin C would reduce the risk of pneumonia in the general population, however, four trials reported a treatment benefit for pneumonia patients, although the findings encourage further research rather than providing firm evidence of efficacy. Vitamin C has been tested for COVID-19 and sepsis with conflicting results. Given the evidence that vitamin C reduces the severity and duration of the common cold, and the safety and low cost, it is not unreasonable for individuals to test whether 6-8 g/day is beneficial at the individual level.

Conflict of interest None declared. Open access This is an Open Access article distributed under the terms of the Creative Commons Attribution 4.0 International License (CC BY 4.0), allowing anyone to copy and redistribute the material in any medium or format and to remix, transform, and build upon the material, including commercial purposes, provided the original work is properly cited. How to cite

References

Adhikari, Hashmi, Vijayaraghavan, Intravenous vitamin C for patients hospitalized with COVID-19: two harmonized randomized clinical trials, JAMA, doi:10.1001/jama.2023.21407

Anah, Jarike, Baig, High dose ascorbic acid in Nigerian asthmatics, Trop Geogr Med, doi:10.5281/zenodo.13912250

Anderson, Beaton, Corey, Spero, Winter illness and vitamin C: the effect of relatively low doses, Can Med Assoc J

Anderson, Reid, Beaton, Vitamin C and the common cold: a double-blind trial, Can Med Assoc J

Anderson, Suranyi, Beaton, The effect on winter illness of large doses of vitamin C, Can Med Assoc J

Asfora, Vitamin C in high doses in the treatment of the common cold, Int J Vitam Nutr Res, doi:10.5281/zenodo.13969355

Baird, Hughes, Wilson, The effects of ascorbic acid and flavonoids on the occurrence of symptoms normally associated with the common cold, Am J Clin Nutr, doi:10.1093/ajcn/32.8.1686

Balduzzi, Rücker, Schwarzer, How to perform a meta-analysis with R: a practical tutorial, Evid Based Ment Health, doi:10.1136/ebmental-2019-300117

Bates, Schorah, Hemilä, Vitamin C intake and susceptibility to the common cold: Invited commentaries and response, Br J Nutr, doi:10.1079/BJN19970201

Bee, The vitamin C controversy, Postgrad Med, doi:10.1080/00325481.1980.11715362

Bergsten, Amitai, Kehrl, Millimolar concentrations of ascorbic acid in purified human mononuclear leukocytes, J Biol Chem, doi:10.1016/S0021-9258(19)39841-2

Bessel-Lorck, Common cold prophylaxis in young people at a ski-camp, Medizinische, doi:10.5281/zenodo.6514016

Bielsa-Berrocal, COVID-19: up to 82% critically ill patients had low vitamin C values, Nutr J, doi:10.1186/s12937-021-00727-z

Bohnholtzer, Contribution to the question of pneumonia treatment with vitamin C, Dtsch Med Wochenschr, doi:10.5281/zenodo.6406564

Bucca, Rolla, Arossa, Effect of ascorbic acid on increased bronchial responsiveness during upper airway infection, Respiration, doi:10.1159/000195737

Carr, Einstein, Lai, Vitamin C and the common cold: a second MZ Cotwin control study, Acta Genet Med Gemellol, doi:10.1017/s0001566000006450

Cathcart, Vitamin C, titrating to bowel tolerance, anascorbemia, and acute induced scurvy, Med Hypotheses, doi:10.1016/0306-9877(81)90126-2

Chambers, Storer, Scott-Thomas, Adjunctive intravenous then oral vitamin C for moderate and severe community-acquired pneumonia in hospitalized adults: feasibility of randomized controlled trial, Sci Rep, doi:10.1038/s41598-023-37934-z

Chiscano-Camón, Ruiz-Rodriguez, Plata-Menchaca, Vitamin C deficiency in critically ill COVID-19 patients admitted to intensive care unit, Front Med, doi:10.3389/fmed.2023.1301001

Clegg, Macdonald, L-Ascorbic acid and D-isoascorbic acid in a common cold survey, Am J Clin Nutr, doi:10.1093/ajcn/28.9.973

Constantini, Dubnov-Raz, Eyal, The effect of vitamin C on upper respiratory infections in adolescent swimmers: a randomized trial, Eur J Pediatr, doi:10.1007/s00431-010-1270-z

De Grooth, Elbers, Vincent, Vitamin C for sepsis and acute respiratory failure, JAMA, doi:10.1001/jama.2019.21987

Elliott, Ascorbic acid: efficacy in the prevention of symptoms of respiratory infection on a Polaris submarine, IRCS International Research Communications System, doi:10.5281/zenodo.13945907

Elwood, Lee, Leger, A randomized controlled trial of vitamin C in the prevention and amelioration of the common cold, Br J Prev Soc Med, doi:10.1136/jech.30.3.193

Fowler, Truwit, Hite, Effect of vitamin C infusion on organ failure and biomarkers of inflammation and vascular injury in patients with sepsis and severe acute respiratory failure: the CITRIS-ALI randomized clinical trial, JAMA, doi:10.1001/jama.2019.11825

Galley, Davies, Webster, Ascorbyl radical formation in patients with sepsis: effect of ascorbate loading, Free Radic Biol Med, doi:10.1016/0891-5849(95)02022-5

Gander, Niederberger, Vitamin C in the treatment of pneumonia, Munch Med Wochenschr, doi:10.5281/zenodo.6406760

Glasziou, Sanders, Hoffmann, Waste in covid-19 research. A deluge of poor quality research is sabotaging an effective evidence based response, BMJ, doi:10.1136/bmj.m1847

Glazebrook, Thomson, The administration of vitamin C in a large institution and its effect on general health and resistance to infection, J Hyg (Lond), doi:10.1017/s0022172400012596

Gotzsche, Pernasal vitamin C and the common cold, Lancet, doi:10.1016/s0140-6736(89)91046-5

Hemilä, Carr, Chalker, Vitamin C may increase the recovery rate of outpatient cases of SARS-CoV-2 infection by 70%: reanalysis of the COVID A to Z randomized clinical trial, Front Immunol, doi:10.3389/fimmu.2021.674681

Hemilä, Chalker, Abrupt termination of vitamin C from ICU patients may increase mortality: secondary analysis of the LOVIT trial, Eur J Clin Nutr, doi:10.1038/s41430-022-01254-8

Hemilä, Chalker, Bias against vitamin C in mainstream medicine: examples from trials of vitamin C for infections, Life, doi:10.3390/life12010062

Hemilä, Chalker, Commentary: Vitamin C supplementation for prevention and treatment of pneumonia, Front Med, doi:10.3389/fmed.2020.595988

Hemilä, Chalker, Concerns with the revised Japanese recommendation for administering vitamin C to septic patients, J Intensive Care, doi:10.1186/s40560-023-00702-2

Hemilä, Chalker, Meta-analysis on vitamin C and the common cold in children may be misleading, Eur J Clin Pharmacol, doi:10.1007/s00228-019-02733-x

Hemilä, Chalker, Reanalysis of the effect of vitamin C on mortality in the CITRIS-ALI trial: important findings dismissed in the trial report, Front Med, doi:10.3389/fmed.2020.590853

Hemilä, Chalker, Rebound effect explains the divergence in survival after 5 days in a controlled trial on vitamin C for COVID-19 patients, Front Med, doi:10.3389/fmed.2024.1391346

Hemilä, Chalker, Vitamin C and the common cold in children: severe flaws in the meta-analyses by Vorilhon et al, Zenodo, doi:10.5281/zenodo.6395731

Hemilä, Chalker, Vitamin C can shorten the length of stay in the ICU: a metaanalysis, Nutrients, doi:10.3390/nu11040708

Hemilä, Chalker, Vitamin C for patients with sepsis?, Front Med, doi:10.3389/fmed.2024.1450091

Hemilä, Chalker, Vitamin C for preventing and treating the common cold, Cochrane Database Syst Rev, doi:10.1002/14651858.cd000980.pub4

Hemilä, Chalker, Vitamin C may reduce the duration of mechanical ventilation in critically ill patients: a meta-regression analysis, J Intensive Care, doi:10.1186/s40560-020-0432-y

Hemilä, Chalker, Vitamin C reduces the severity of common colds: a meta-analysis, BMC Public Health, doi:10.1186/s12889-023-17229-8

Hemilä, De Man, Vitamin C and COVID-19, Front Med, doi:10.3389/fmed.2020.559811

Hemilä, Do vitamins C and E affect respiratory infections?, doi:10.5281/zenodo.6395595

Hemilä, Effect of vitamin C deprivation on the duration of colds in the Sheffield Study: a statistical analysis

Hemilä, Herman, Vitamin C and the common cold: a retrospective analysis of Chalmers' review, J Am Coll Nutr, doi:10.1080/07315724.1995.10718483

Hemilä, Hess, Trotter, The symptoms of vitamin C deficiency. 1. Observations and descriptions by, Zenodo, doi:10.5281/zenodo.10685194

Hemilä, Louhiala, Vitamin C for preventing and treating pneumonia, Cochrane Database Syst Rev, doi:10.1002/14651858.cd005532.pub3

Hemilä, Vitamin C and common cold-induced asthma: a systematic review and statistical analysis, Allergy Asthma Clin Immunol, doi:10.1186/1710-1492-9-46

Hemilä, Vitamin C and infections, Nutrients, doi:10.3390/nu9040339

Hemilä, Vitamin C and sex differences in respiratory tract infections, Respir Med, doi:10.1016/j.rmed.2007.12.011

Hemilä, Vitamin C for preventing and treating the common cold

Hemilä, Vitamin C intake and susceptibility to the common cold, Br J Nutr, doi:10.1017/s0007114500002889

Hemilä, Vitamin C supplementation and common cold symptoms: factors affecting the magnitude of the benefit, Med Hypotheses, doi:10.1054/mehy.1997.0639

Hemilä, Vitamin C supplementation and common cold symptoms: problems with inaccurate reviews, Nutrition, doi:10.1016/s0899-9007(96)00223-7

Hemilä, Vitamin C supplementation and respiratory infections: a systematic review, Mil Med, doi:10.7205/milmed.169.11.920

Hemilä, Vitamin E administration may decrease the incidence of pneumonia in elderly males, Clin Interv Aging, doi:10.2147/cia.s114515

Hemilä, Vitamin E and the risk of pneumonia: using the I 2 statistic to quantify heterogeneity within a controlled trial, Br J Nutr, doi:10.1017/s0007114516003408

Hemilä, Vitamin, the placebo effect, and the common cold: a case study of how preconceptions influence the analysis of results, J Clin Epidemiol, doi:10.1016/0895-4356(96)00189-8

Hess, Scurvy: past and present

Hochwald, Vitamin C in the treatment of croupous pneumonia, Dtsch Med Wochenschr, doi:10.5281/zenodo.6406698

Hunt, Chakravorty, Annan, The clinical effects of vitamin C supplementation in elderly hospitalised patients with acute respiratory infections, Int J Vitam Nutr Res, doi:10.5281/zenodo.6406235

Jung, Lee, Baek, Kim, Vitamin C for ≥5 days is associated with decreased hospital mortality in sepsis subgroups: a nationwide cohort study, Crit Care, doi:10.1186/s13054-021-03872-3

Karlowski, Chalmers, Frenkel, Ascorbic acid for the common cold: a prophylactic and therapeutic trial, JAMA, doi:10.1001/jama.1975.03240220018013

Kimbarowski, Mokrow, Colored precipitation reaction of the urine according to Kimbarowski (FARK) as an index of the effect of ascorbic acid during treatment of viral influenza, Dtsch Gesundheitsw, doi:10.5281/zenodo.7116182

Klenner, Virus pneumonia and its treatment with vitamin C, South Med Surg, doi:10.5281/zenodo.10932789

Lamontagne, Masse, Menard, Intravenous vitamin C in adults with sepsis in the intensive care unit, N Engl J Med, doi:10.1056/nejmoa2200644

Li, Maeda, Beck, Vitamin C deficiency increases the lung pathology of influenza virus-infected gulo-/-mice, J Nutr, doi:10.1093/jn/136.10.2611

Louhiala, Hemilä, Can CAM treatments be evidence-based?, Focus Altern Complement Ther, doi:10.1111/fct.12110

Ludvigsson, Hansson, Tibbling, Vitamin C as a preventive medicine against common colds in children, Scand J Infect Dis, doi:10.3109/inf.1977.9.issue-2.07

Mahmoodpoor, Shadvar, Sanaie, Effect of Vitamin C on mortality of critically ill patients with severe pneumonia in intensive care unit: a preliminary study, BMC Infect Dis, doi:10.1186/s12879-021-06288-0

Marik, Khangoora, Rivera, Hydrocortisone, vitamin C, and thiamine for the treatment of severe sepsis and septic shock: a retrospective before-after study, Chest, doi:10.1016/j.chest.2016.11.036

Markwell, Vitamin C in the prevention of colds, Med J Australia, doi:10.5694/j.1326-5377.1947.tb74386.x

Merchant, Curhan, Bendich, Vitamin intake is not associated with community-acquired pneumonia in U.S. men, J Nutr, doi:10.1093/jn/134.2.439

Miegl, Use of vitamin C in otorhinolaryngology [in German; translation available, Wien Med Wochenschr, doi:10.5281/zenodo.6514695

Miller, Nance, Norton, Therapeutic effect of vitamin C: a co-twin control study, JAMA, doi:10.1001/jama.1977.03270300052006

Mochalkin, Ascorbic acid in the complex therapy of acute, Voenno-Meditsinskii Zhurnal, doi:10.5281/zenodo.7097483

Moolla, The role of anti-oxidants in the prevention of post-race upper respiratory tract infection

Murphy, Krushak, Maynard, Ascorbic acid (vitamin C) and its effects on parainfluenza type 3 virus infection in cotton-topped marmosets, Lab Anim Sci, doi:10.5281/zenodo.13946384

Pauling, Ascorbic acid and the common cold. Part II, Medical Tribune, doi:10.5281/zenodo.11547088

Pauling, Ascorbic acid and the common cold: Evaluation of its efficacy and toxicity, Part I. Medical Tribune, doi:10.5281/zenodo.11546757

Pauling, The significance of the evidence about ascorbic acid and the common cold, Proc Natl Acad Sci, doi:10.1073/pnas.68.11.2678

Peters, Goetzsche, Grobbelaar, Noakes, Vitamin C supplementation reduces the incidence of postrace symptoms of upper-respiratory-tract infection in ultramarathon runners, Am J Clin Nutr, doi:10.1093/ajcn/57.2.170

Peters, Goetzsche, Joseph, Noakes, Vitamin C as effective as combinations of antioxidant nutrients in reducing symptoms of upper respiratory tract infection in ultramarathon runners, S Afr J Sports Med, doi:10.5281/zenodo.13912478

Pitt, Costrini, Vitamin C prophylaxis in marine recruits, JAMA, doi:10.1001/jama.1979.03290350028016

Ritzel, Critical analysis of the role of vitamin C in the prophylaxis and treatment of the common cold, Helv Med Acta, doi:10.5281/zenodo.6546378

Robertson, The vitamins and resistance to infection, Medicine, doi:10.5281/zenodo.14496927

Ruskin, Calcium cevitamate in the treatment of acute rhinitis, Ann Otol Rhinol Laryngol, doi:10.5281/zenodo.14494040

Sabiston, Radomski, Health problems and vitamin C in Canadian Northern Military operations, doi:10.5281/zenodo.7303680

Schertling, Winsel, Müller, Action of ascorbic acid on clinical course of infection related bronchial asthma and on reactive oxygen metabolites by BAL cells, Z Klin Med, doi:10.5281/zenodo.7115702

Shamseer, Vohra, Bax, Commentaries on 'Vitamin C for preventing and treating the common cold' with responses from the review author, Evid Based Child Health: A Cochrane Rev J, doi:10.1002/ebch.261

Tanaka, Matsuda, Miyagantani, Reduction of resuscitation fluid volumes in severely burned patients using ascorbic acid administration: a randomized, prospective study, Arch Surg, doi:10.1001/archsurg.135.3.326

Thomas, Patel, Bittel, Effect of high-dose zinc and ascorbic acid supplementation vs usual care on symptom length and reduction among ambulatory patients with SARS-CoV-2 infection: the COVID A to Z randomized clinical trial, JAMA Netw Open, doi:10.1001/jamanetworkopen.2021.0369

Vitamin, In: Dietary reference values for food energy and nutrients for the United Kingdom. Report of the Panel on Dietary Reference Values of the Committee on Medical Aspects of Food Policy, Rep Health Soc Subj (Lond), doi:10.5281/zenodo.13946536

Vorilhon, Arpajou, Roussel, Retraction note: efficacy of vitamin C for the prevention and treatment of upper respiratory tract infection: a meta-analysis in children, Eur J Clin Pharmacol, doi:10.1007/s00228-021-03150-9

Wilson, Evaluation of vitamin C for adjuvant sepsis therapy, Antioxid Redox Signal, doi:10.1089/ars.2013.5401

DOI record: { "DOI": "10.20452/pamw.16926", "ISSN": [ "1897-9483" ], "URL": "http://dx.doi.org/10.20452/pamw.16926", "author": [ { "affiliation": [], "family": "Hemilä", "given": "Harri", "sequence": "first" }, { "affiliation": [], "family": "Chalker", "given": "Elizabeth", "sequence": "additional" } ], "container-title": "Polish Archives of Internal Medicine", "content-domain": { "crossmark-restriction": false, "domain": [] }, "created": { "date-parts": [ [ 2025, 1, 13 ] ], "date-time": "2025-01-13T11:12:42Z", "timestamp": 1736766762000 }, "deposited": { "date-parts": [ [ 2025, 1, 13 ] ], "date-time": "2025-01-13T11:12:42Z", "timestamp": 1736766762000 }, "indexed": { "date-parts": [ [ 2025, 1, 14 ] ], "date-time": "2025-01-14T05:20:11Z", "timestamp": 1736832011513, "version": "3.33.0" }, "is-referenced-by-count": 0, "issued": { "date-parts": [ [ 2025, 1, 13 ] ] }, "link": [ { "URL": "https://www.mp.pl/paim/en/node/16926/pdf", "content-type": "unspecified", "content-version": "vor", "intended-application": "similarity-checking" } ], "member": "8469", "original-title": [], "prefix": "10.20452", "published": { "date-parts": [ [ 2025, 1, 13 ] ] }, "published-print": { "date-parts": [ [ 2025, 1, 13 ] ] }, "publisher": ""Medycyna Praktyczna" Spolka Jawna", "reference-count": 0, "references-count": 0, "relation": {}, "resource": { "primary": { "URL": "https://www.mp.pl/paim/issue/article/16926" } }, "score": 1, "short-title": [], "source": "Crossref", "subject": [], "subtitle": [], "title": "Vitamin C for the common cold and pneumonia", "type": "journal-article" }

Please send us corrections, updates, or comments. c19early involves the extraction of 200,000+ datapoints from thousands of papers. Community updates help ensure high accuracy. Treatments and other interventions are complementary. All practical, effective, and safe means should be used based on risk/benefit analysis. No treatment or intervention is 100% available and effective for all current and future variants. We do not provide medical advice. Before taking any medication, consult a qualified physician who can provide personalized advice and details of risks and benefits based on your medical history and situation. IMA and WCH provide treatment protocols.

Submit

Post

@CovidAnalysis

FAQ

Public domain CC0 1.0